Literature DB >> 18556959

Lost lessons of glucocorticoid potency and the treatment of children with congenital adrenal hyperplasia.

Scott A Rivkees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18556959     DOI： 10.1515/jpem.2008.21.4.297

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN： 0334-018X            Impact factor:   1.634


× No keyword cloud information.
  3 in total

1.  Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the "growth toxic" glucocorticoid.

Authors:  Scott A Rivkees
Journal:  Int J Pediatr Endocrinol       Date:  2010-04-15

Review 2.  Management of adolescents with congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Dix P Poppas
Journal:  Lancet Diabetes Endocrinol       Date:  2013-11-15       Impact factor: 32.069

3.  Ultralow-dose Dexamethasone to Preserve Endogenous Cortisol Stress Response in Nonclassical Congenital Adrenal Hyperplasia: A New Promising Treatment.

Authors:  Danielle van der Kaay; Erica van den Akker
Journal:  Int J Endocrinol Metab       Date:  2014-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.